Stephen P. Fink

1.9k total citations
31 papers, 1.1k citations indexed

About

Stephen P. Fink is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Stephen P. Fink has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Pharmacology. Recurrent topics in Stephen P. Fink's work include Inflammatory mediators and NSAID effects (10 papers), Genetic factors in colorectal cancer (8 papers) and DNA Repair Mechanisms (7 papers). Stephen P. Fink is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Genetic factors in colorectal cancer (8 papers) and DNA Repair Mechanisms (7 papers). Stephen P. Fink collaborates with scholars based in United States, South Korea and Canada. Stephen P. Fink's co-authors include Lawrence J. Marnett, Sanford D. Markowitz, G. Ramachandra Reddy, Robley C. Williams, James K. V. Willson, Debra Mikkola, Joseph Willis, James Lutterbaugh, Petra Platzer and Jill S. Barnholtz‐Sloan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Stephen P. Fink

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen P. Fink United States 17 646 292 256 163 160 31 1.1k
Ming‐Chung Jiang Taiwan 14 647 1.0× 155 0.5× 272 1.1× 82 0.5× 119 0.7× 18 951
Hyun Ho Choi South Korea 19 777 1.2× 227 0.8× 292 1.1× 68 0.4× 113 0.7× 30 1.0k
Xu Di United States 19 790 1.2× 216 0.7× 336 1.3× 78 0.5× 102 0.6× 25 1.4k
Napoleón Navarro‐Tito Mexico 20 595 0.9× 432 1.5× 296 1.2× 75 0.5× 79 0.5× 53 1.2k
Pamela A. Havre United States 20 897 1.4× 267 0.9× 379 1.5× 57 0.3× 85 0.5× 33 1.4k
Jui-Wen Huang Taiwan 14 809 1.3× 261 0.9× 309 1.2× 123 0.8× 57 0.4× 19 1.2k
Ruilan Yan United States 13 725 1.1× 166 0.6× 197 0.8× 89 0.5× 505 3.2× 19 1.1k
Aruna S. Jaiswal United States 23 1.2k 1.8× 292 1.0× 485 1.9× 68 0.4× 92 0.6× 51 1.5k
Jenq-Chang Lee Taiwan 18 758 1.2× 374 1.3× 242 0.9× 41 0.3× 100 0.6× 31 1.1k
Sven A. Lang Germany 24 928 1.4× 298 1.0× 449 1.8× 46 0.3× 121 0.8× 44 1.5k

Countries citing papers authored by Stephen P. Fink

Since Specialization
Citations

This map shows the geographic impact of Stephen P. Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen P. Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen P. Fink more than expected).

Fields of papers citing papers by Stephen P. Fink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen P. Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen P. Fink. The network helps show where Stephen P. Fink may publish in the future.

Co-authorship network of co-authors of Stephen P. Fink

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen P. Fink. A scholar is included among the top collaborators of Stephen P. Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen P. Fink. Stephen P. Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Wei, Hongyun Li, Janna Kiselar, et al.. (2023). Small molecule inhibitors of 15-PGDH exploit a physiologic induced-fit closing system. Nature Communications. 14(1). 784–784. 7 indexed citations
2.
Fink, Stephen P., et al.. (2023). Enzymatic Resolution and Decarboxylative Functionalization of α‐Sulfinyl Esters. Chemistry - A European Journal. 30(7). e202302996–e202302996. 2 indexed citations
3.
Hu, Bin, Kosuke Toda, Xiaoyu Wang, et al.. (2022). Orally Bioavailable Quinoxaline Inhibitors of 15-Prostaglandin Dehydrogenase (15-PGDH) Promote Tissue Repair and Regeneration. Journal of Medicinal Chemistry. 65(22). 15327–15343. 8 indexed citations
4.
Yim, Kwangil, et al.. (2020). Novel Pathologic Factors for Risk Stratification of Gastric “Indefinite for Dysplasia” Lesions. Gastroenterology Research and Practice. 2020. 1–11.
5.
Kim, Jaeil, Eunju Do, Helen Moinova, et al.. (2017). Molecular Imaging of Colorectal Tumors by Targeting Colon Cancer Secreted Protein-2 (CCSP-2). Neoplasia. 19(10). 805–816. 16 indexed citations
6.
Cummings, Linda C., Prashanthi N. Thota, Joseph Willis, et al.. (2017). A nonrandomized trial of vitamin D supplementation for Barrett’s esophagus. PLoS ONE. 12(9). e0184928–e0184928. 9 indexed citations
7.
Guda, Kishore, Stephen P. Fink, Ginger L. Milne, et al.. (2014). Inactivating Mutation in the Prostaglandin Transporter Gene, SLCO2A1 , Associated with Familial Digital Clubbing, Colon Neoplasia, and NSAID Resistance. Cancer Prevention Research. 7(8). 805–812. 27 indexed citations
8.
Choi, Sung Hee, Byung‐Gyu Kim, Janet Robinson, et al.. (2014). Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis. Journal of Clinical Investigation. 124(6). 2472–2482. 43 indexed citations
9.
Fink, Stephen P., Dawn Dawson, Yongyou Zhang, et al.. (2014). Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs. Carcinogenesis. 36(2). 291–298. 13 indexed citations
10.
Myung, Seung‐Jae, Young Soo Park, Dong‐Hoon Yang, et al.. (2013). Inhibition of 15-Hydroxyprostaglandin Dehydrogenase by Helicobacter pylori in Human Gastric Carcinogenesis. Cancer Prevention Research. 6(4). 349–359. 11 indexed citations
11.
Fink, Stephen P., Dong‐Hoon Yang, Jill S. Barnholtz‐Sloan, et al.. (2013). Colonic 15-PGDH Levels Are Stable Across Distance and Time and Are Not Perturbed by Aspirin Intervention. Digestive Diseases and Sciences. 58(9). 2615–2622. 6 indexed citations
12.
Thompson, Cheryl L., Stephen P. Fink, James Lutterbaugh, et al.. (2013). Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility. PLoS ONE. 8(5). e64122–e64122. 10 indexed citations
13.
Song, Ho June, Seung‐Jae Myung, Young Soo Park, et al.. (2011). 15-Hydroxyprostaglandin Dehydrogenase is Downregulated and Exhibits Tumor Suppressor Activity in Gastric Cancer. Cancer Investigation. 29(4). 257–265. 23 indexed citations
14.
Guo, Chunguang, Xiaodong Zhang, Stephen P. Fink, et al.. (2008). Ugene, a Newly Identified Protein That Is Commonly Overexpressed in Cancer and Binds Uracil DNA Glycosylase. Cancer Research. 68(15). 6118–6126. 40 indexed citations
15.
Fink, Stephen P., Debra Mikkola, James K. V. Willson, & Sanford D. Markowitz. (2003). TGF-β-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines. Oncogene. 22(9). 1317–1323. 79 indexed citations
16.
Myeroff, Lois L., et al.. (2003). Mutation Detection in the TGF-β Receptors and smad Genes: RT-PCR and Sequencing. Humana Press eBooks. 142. 139–147. 1 indexed citations
17.
18.
Mierzwa, Michelle, et al.. (1999). MutS Recognition of Exocyclic DNA Adducts That Are Endogenous Products of Lipid Oxidation. Journal of Biological Chemistry. 274(38). 27112–27118. 30 indexed citations
19.
Fink, Stephen P., G. Ramachandra Reddy, & Lawrence J. Marnett. (1997). Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde. Proceedings of the National Academy of Sciences. 94(16). 8652–8657. 119 indexed citations
20.
Fink, Stephen P., et al.. (1993). Taxol-induced flexibility of microtubules and its reversal by MAP-2 and Tau.. Journal of Biological Chemistry. 268(10). 6847–6850. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming‐Chung Jiang Breakdown of academic impact, for papers by Hyun Ho Choi Breakdown of academic impact, for papers by Xu Di Breakdown of academic impact, for papers by Napoleón Navarro‐Tito Breakdown of academic impact, for papers by Pamela A. Havre Breakdown of academic impact, for papers by Jui-Wen Huang Breakdown of academic impact, for papers by Ruilan Yan Breakdown of academic impact, for papers by Aruna S. Jaiswal Breakdown of academic impact, for papers by Jenq-Chang Lee Breakdown of academic impact, for papers by Sven A. Lang
Rankless by CCL
2026